We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Lemonade
LMND
$4.1B
| $2.69M | ﹤0.01% |
40,142
+4,649
| +13% | +$375K |
|
|
HIBB
1727
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.69M | ﹤0.01% |
38,020
-7,975
| -17% | -$696K |
|
|
FIRY
1728
Firy Inc
FIRY
$163M
| $2.69M | ﹤0.01% |
13,680
+429
| +3% | +$111K |
|
1729
Apogee Enterprises
APOG
$908M
| $2.68M | ﹤0.01% |
71,007
-10,501
| -13% | -$422K |
|
1730
Genesco
GCO
$422M
| $2.67M | ﹤0.01% |
46,293
-5,408
| -10% | -$322K |
|
1731
Andersons Inc
ANDE
$2.22B
| $2.67M | ﹤0.01% |
86,548
-10,713
| -11% | -$309K |
|
|
HTLF
1732
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.66M | ﹤0.01% |
55,399
+1,338
| +2% | +$62.1K |
|
1733
Celldex Therapeutics
CLDX
$3.28B
| $2.66M | ﹤0.01% |
49,265
+8,430
| +21% | +$396K |
|
1734
Adtran
ADTN
$616M
| $2.66M | ﹤0.01% |
141,603
-18,998
| -12% | -$400K |
|
1735
PC Connection
CNXN
$2.12B
| $2.65M | ﹤0.01% |
60,234
+8,168
| +16% | +$374K |
|
|
TDAY
1736
USA Today Co
TDAY
$1.06B
| $2.65M | ﹤0.01% |
396,695
-42,492
| -10% | -$250K |
|
1737
Heritage Financial
HFWA
$1.21B
| $2.65M | ﹤0.01% |
103,834
-13,062
| -11% | -$317K |
|
1738
Community Health Systems
CYH
$423M
| $2.64M | ﹤0.01% |
226,009
-47,742
| -17% | -$623K |
|
1739
JELD-WEN Holding
JELD
$164M
| $2.64M | ﹤0.01% |
105,431
+2,246
| +2% | +$59.9K |
|
|
DOOR
1740
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.63M | ﹤0.01% |
24,824
+375
| +2% | +$42.6K |
|
1741
National Healthcare
NHC
$3.38B
| $2.63M | ﹤0.01% |
37,550
+19,150
| +104% | +$1.39M |
|
1742
Scansource
SCSC
$1.12B
| $2.63M | ﹤0.01% |
75,540
-8,063
| -10% | -$248K |
|
|
SFIX
1743
Stitch Fix
SFIX
$560M
| $2.63M | ﹤0.01% |
65,706
-1,495
| -2% | -$69.9K |
|
|
AAN
1744
DELISTED
The Aaron's Company Inc
AAN
| $2.63M | ﹤0.01% |
95,326
-15,202
| -14% | -$427K |
|
1745
Nelnet
NNI
$4.7B
| $2.62M | ﹤0.01% |
33,095
+635
| +2% | +$49.1K |
|
|
AGNT
1746
AGNT Inc
AGNT
$734M
| $2.62M | ﹤0.01% |
65,804
+2,446
| +4% | +$105K |
|
|
NTUS
1747
DELISTED
Natus Medical Inc
NTUS
| $2.62M | ﹤0.01% |
104,353
-12,682
| -11% | -$323K |
|
|
INVX
1748
Innovex International
INVX
$1.97B
| $2.61M | ﹤0.01% |
103,704
-13,361
| -11% | -$355K |
|
1749
Cass Information Systems
CASS
$743M
| $2.61M | ﹤0.01% |
62,322
+18,414
| +42% | +$784K |
|
1750
SiTime
SITM
$21.8B
| $2.6M | ﹤0.01% |
12,761
+975
| +8% | +$174K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.